Oncogenic Role of ADAM32 in Hepatoblastoma: A Potential Molecular Target for Therapy.

MLA

Fukazawa, Takahiro, et al. “Oncogenic Role of ADAM32 in Hepatoblastoma: A Potential Molecular Target for Therapy.” Cancers, vol. 14, no. 19, Oct. 2022, p. 4732. EBSCOhost, https://doi.org/10.3390/cancers14194732.

APA

Fukazawa, T., Tanimoto, K., Yamaoka, E., Kojima, M., Kanawa, M., Hirohashi, N., & Hiyama, E. (2022). Oncogenic Role of ADAM32 in Hepatoblastoma: A Potential Molecular Target for Therapy. Cancers, 14(19), 4732. https://doi.org/10.3390/cancers14194732

Chicago

Fukazawa, Takahiro, Keiji Tanimoto, Emi Yamaoka, Masato Kojima, Masami Kanawa, Nobuyuki Hirohashi, and Eiso Hiyama. 2022. “Oncogenic Role of ADAM32 in Hepatoblastoma: A Potential Molecular Target for Therapy.” Cancers 14 (19): 4732. doi:10.3390/cancers14194732.